Testosterone Treatment in Men With Chronic Kidney Disease

Testosterone Treatment in Men With Chronic Kidney Disease

Layout table for additonal information

Responsible Party:
Sandeep Singh Dhindsa, M.D., F.A.C.E, Professor of Medicine, St. Louis University

ClinicalTrials.gov Identifier:

Other Study ID Numbers:

First Posted:
February 21, 2022    Key Record Dates

Last Update Posted:
March 14, 2023

Last Verified:
March 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Layout table for additional information

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Product Manufactured in and Exported from the U.S.:

Keywords provided by Sandeep Singh Dhindsa, M.D., F.A.C.E, St. Louis University:


Additional relevant MeSH terms:

Layout table for MeSH terms

Kidney DiseasesRenal Insufficiency, ChronicHypogonadismEunuchismUrologic DiseasesRenal InsufficiencyGonadal Disorders
Endocrine System DiseasesTestosteroneAndrogensHormonesHormones, Hormone Substitutes, and Hormone AntagonistsPhysiological Effects of Drugs

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 15, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine